<DOC>
	<DOCNO>NCT01583647</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics laropiprant follow administration single dose 1 ( Panel A ) 2 ( Panel B ) combination tablet MK-0524A adolescent heterozygous familial hypercholesterolemia .</brief_summary>
	<brief_title>A Study Extended-release ( ER ) Niacin/Laropiprant Adolescents With Heterozygous Familial Hypercholesterolemia ( MK-0524A-158 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Postpubescent adolescent age 10 16 heterozygous familial hypercholesterolemia Agree use ( and/or partner use ) acceptable method birth control begin prestudy visit least 2 week dose study drug Height weight fall 10th 95th percentile age minimum body weight 23 kg Receiving appropriate medical care hypercholesterolemia , statin lipidmodifying therapy . History psychiatric personality disorder may affect patient 's ability participate History stroke , chronic seizure , major neurological disorder History clinically significant endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality disease ( exclude lipid abnormality ) Poorly control recently diagnose Type 1 Type 2 diabetes mellitus History neoplastic disease within previous 5 year Consumes alcohol excessive amount product contain caffeine ( e.g . cola ) Has major surgery , donate and/or receive blood within previous 8 week Participated another investigational study within previous 4 week History significant multiple and/or severe allergy ( include latex allergy ) , anaphylactic reaction significant intolerability prescription nonprescription drug food Positive hepatitis B surface antigen , hepatitis C antibodies human immunodeficiency virus ( HIV ) Can swallow large tablet Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>